| Financial Year |
March 31 2023 |
| Monetary Funds |
2,912,803,167.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,712,639.62 |
| Accounts Receivable |
2,630,972,321.12 |
| Advances to Suppliers |
222,960,115.71 |
| Other Receivables |
400,257,020.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
426,491,346.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
720,302,686.77 |
| Other Current Assets |
123,166,291.73 |
| Total Current Assets |
12,772,093,849.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,787,204,731.55 |
| Long-term Equity Investment |
750,146,206.03 |
| Investment Properties |
-- |
| Fixed Assetes |
422,186,304.93 |
| Under-construction Projects |
4,934,807.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
244,691,103.37 |
| R&D expenses |
-- |
| Goodwill |
753,119,614.61 |
| Long-Term Deferred and Prepaid Expenses |
6,762,763.33 |
| Deferred Income Tax Assets |
470,686,747.18 |
| Other Non-Current Assets |
14,224,165,220.48 |
| Sub-Total of Non-Current Assets |
18,982,363,340.03 |
| Total Assets |
31,754,457,189.90 |
| Short-Term Loans |
9,477,909,103.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
47,971,228.18 |
| Accounts Payable |
5,257,536,050.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
103,480,181.75 |
| Taxes Payable |
124,137,217.08 |
| Interest Payable |
47,570.83 |
| Dividend Payable |
3,882,139.45 |
| Other payables |
729,534,585.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,872,873,097.28 |
| Other Current Liabilities |
1,213,508,285.27 |
| Sub-Total of Current Liabilities |
19,117,942,981.69 |
| Long-term Loans |
5,404,594,288.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,224,923.97 |
| Other Non-Current Liabilities |
52,946,614.59 |
| Sub-Total of Non-Current Liabilities |
5,598,993,194.70 |
| Total Liabilities |
24,716,936,176.39 |
| Paid-In Capital(Or Share Stock) |
2,822,873,062.00 |
| Capital Surplus |
2,625,698,445.08 |
| Surplus Reserve |
218,619,228.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-174,790,831.90 |
| Minority Stockholder's Interest |
576,518,921.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,461,002,092.04 |
| Owner's Equity（Stockholder's Equity） |
7,037,521,013.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,754,457,189.90 |
